Trends in cancer drug revenue retained by providers under buy-and-bill reimbursement, 2010-2024.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aaron Philip Mitchell, Aaron N. Winn, Ziad Zakaria, Srividya Vempati, Christie Lee Luo, Jyotirmoy Sarker, Maria Klimchuk, Pragya Kakani
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7162543656
Cites:
Cited by:
Related to: